CT剂量学:已取得的成就与尚待完成的工作
本文综述CT辐射剂量表征中最常用的指标及其优缺点,并介绍患者剂量评估方法。CT剂量学仍基于CTDI100,其低估宽束准直现代CT的剂量;SSDE、有效剂量和蒙特卡罗模拟各有局限,个体化剂量学尚不实用,未来需发展先进人工智能算法。
要点
- CTDI100易测量但会低估宽束准直现代CT扫描仪的剂量,厂商应在控制台报告校正后的CTDI值。
- SSDE基于CTDI和转换因子计算,仅在管电流调制未激活且患者体径沿z轴变化不大时计算简便。
- 有效剂量不应用于评估个体癌症诱发概率,器官或组织剂量才是所需指标。
核心结论
- CT剂量学仍以CTDI100为基础,但该指标低估宽束准直现代CT的剂量,厂商应报告校正后的CTDI值。
- SSDE、有效剂量和蒙特卡罗模拟各有局限,个体化剂量学尚不便于常规应用,未来需发展先进人工智能算法。
研究设计与样本
- 综述文章,旨在概述CT辐射剂量表征最常用指标、讨论其优缺点并介绍患者剂量评估方法。
诊断标准与关键数值
- CT剂量学仍基于用100毫米长笔形电离室和标准剂量模体测量的CT剂量指数(CTDI100)。
- SSDE基于CTDI和转换因子计算,用于估计沿CT扫描z轴扫描体积中心的平均剂量。
- 器官或组织剂量而非有效剂量用于评估受照个体癌症诱发概率。
临床应用与阅片要点
- 有效剂量可用于提供CT检查的典型患者剂量值、比较不同模态间剂量和沟通辐射风险。
- 实践中有效剂量被错误使用,例如将CT操作表征为低剂量检查。
- 蒙特卡罗模拟是估计CT器官和组织剂量的强大技术,但厂商应向研究界提供建模其CT扫描仪成像过程所需信息。
- 基于蒙特卡罗模拟和患者模型的个体化剂量学可准确估计器官剂量,但不够用户友好且不够快速,无法常规应用。
局限性
- CTDI100易测量但具有重要局限性,低估宽束准直现代CT扫描仪产生的剂量。
- SSDE计算纳入了与CTDI测量相关的不确定性,且仅在管电流调制未激活且患者体径沿z轴变化不大时计算简便。
- 有效剂量在实践中被错误使用,例如将CT操作表征为低剂量检查;评估个体癌症诱发概率需要器官或组织剂量而非有效剂量。
- 厂商应向研究界提供建模其CT扫描仪成像过程所需信息。
- 个体化剂量学不够用户友好且不够快速,无法常规应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Radiation dose in computed tomography (CT) has become a hot topic due to an upward trend in the number of CT procedures worldwide and the relatively high doses associated with these procedures. The main aim of this review article is to provide an overview of the most frequently used metrics for CT radiation dose characterization, discuss their strengths and limitations, and present patient dose assessment methods. Computed tomography dosimetry is still based on a CT dose index (CTDI) measured using 100-mm-long pencil ionization chambers and standard dosimetry phantoms (CTDI100). This dose index is easily measured but has important limitations. Computed tomography dose index underestimates the dose generated by modern CT scanners with wide beam collimation. Manufacturers should report corrected CTDI values in the consoles of CT systems. The size-specific dose estimate has been proposed to provide an estimate of the average dose at the center of the scan volume along the z-axis of a CT scan. Size-specific dose estimate is based on CTDI and conversion factors and, therefore, its calculation incorporates uncertainties associated with the measurement of CTDI. Moreover, the calculation of size-specific dose estimate is straightforward only when the tube current modulation is not activated and when the patient body diameter does not change considerably along the z-axis of the scan. Effective dose can be used to provide typical patient dose values from CT examinations, compare dose between modalities, and communicate radiogenic risks. In practice, effective dose has been used incorrectly, for example, to characterize a CT procedure as a low-dose examination. Organ or tissue doses, not effective doses, are required for assessing the probability of cancer induction in exposed individuals. Monte Carlo simulation is a powerful technique to estimate organ and tissue dose from CT. However, vendors should make available to the research community the required information to model the imaging process of their CT scanners. Personalized dosimetry based on Monte Carlo simulation and patient models allows accurate organ dose estimation. However, it is not user friendly and fast enough to be applied routinely. Future research efforts should involve the development of advanced artificial intelligence algorithms to overcome drawbacks associated with the current equipment-specific and patient-specific dosimetry.
引用
- Damilakis J. CT Dosimetry: What Has Been Achieved and What Remains to Be Done. Invest Radiol. 2021. PMID: 32932380. doi:10.1097/RLI.0000000000000727
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。